PlasmaMED lab attends the 3rd Training School “Cold plasma and combined anticancer therapies” of the PlasTHER Cost Action.

Several integrants of the PlasmaMED lab attended last week the 3rd Training School “Cold plasma and combined anticancer therapies” of the PlasTHER Cost Action.

The event, held in Orléans (France) from the 15th to the 18th of April, 2024, focused on topics such as cancer (type, biology, in vitro and in vivo models), cancer standard treatments, cold plasma for cancer treatments (state-of-the-art, clinical trials, protocols, technological transfer) and combined treatments: plasma + pulsed electric field / photodynamic therapy / chemotherapy.

Since the training school was specially oriented to PhD students and young researchers, all attendees were invited to offer pitch presentations of their work. In terms of the PlasmaMED lab, these were the works presented:

• A.G. Arcoria, F. Tampieri, C. Canal. Hydrogels as models to quantify the distribution and penetration of plasma-generated reactive species on tissues.
• A. Barceló-Rubiño, A. Espona-Noguera, C. Canal. Antibacterial Properties of Plasma-Treated Hydrogels.
• G. Fornabaio, A. Barceló Rubino, C. Canal.  Injectable hydrogels as vehicles to deliver oxidative stress from cold plasmas to induce tumour cytotoxicity. 
• P. Urdalleta Goenaga, JM García-Torres, C. Canal Barnils. Multifunctional hydrogels that combine cold atmospheric plasma (CAP) and magnetoelectric nanoparticles (ME-NP) for treatment of urological cancers.
• M. Živanić, A. Espona-Noguera, A. Privat Maldonado, P. Matušů, F. Tampieri, E. Smits, A. Lin, A. Bogaerts, C. Canal. Plasma-Treated Hydrogels: Local Oxidative Stress Delivery and More.